asa guidelines for glp 1 agonists A narrative review of glucagon-like peptide-1 receptor prior to deep sedation or general anesthesia GLP-1 Receptor Agonists for the
Description
doi: 10.1007/s00125-017-4354-8 132 SammsRJCoghlanMPSloopKWSammsRJCoghlanMPSloopKW

[DOI] [PubMed] [Google Scholar] 45.FDA Approves Dulaglutide for Adults With T2D, Regardless of CVD

Injection site reactions: Redness, itching, or mild swelling at the injection site

Eligible patients were aged 66 years or older, were diagnosed with diabetes and had a minimum follow-up period of one year post diagnosis

In addition, this work provides novel insight into the GLP-1 dynamics, as well as insight into adipocyte changes and mitochondrial function

10.1124/jpet.119.258343 33
